Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer

Published:2014-11-06 Issue:22 Volume:5 Page:11038-11053
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Burkhart Catherine¹,Fleyshman Daria²,Kohrn Rachael¹,Commane Mairead²,Garrigan Jennifer¹,Kurbatov Vadim³,Toshkov Ilya¹,Ramachandran Rajesh³,Martello Laura³,Gurova Katerina V.²

Affiliation:

1. Buffalo Biolabs, LLC, Buffalo, NY, USA

2. Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA

3. Division of Gastroenterology & Hepatology, SUNY Downstate Medical Center, Brooklyn, NY, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation and Evasion of the FEAR Pathway by RNA Viruses;2024-08-22

2. Multiparameter ranking of carbazoles for anti-trypanosome lead discovery;Frontiers in Drug Discovery;2024-08-15

3. Chromatin as an old and new anticancer target;Trends in Cancer;2024-08

4. CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers;2024-02-20

5. Comparison of cell response to chromatin and DNA damage;Nucleic Acids Research;2023-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP